NCT05377294

Brief Summary

The current study aims to test the acceptability and feasibility of a psychological therapy called Method of Levels (MOL) as an intervention for people in acute psychiatric inpatient units who are experiencing psychosis and/or suicidality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 17, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 10, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

May 15, 2023

Status Verified

May 1, 2023

Enrollment Period

6 months

First QC Date

May 8, 2022

Last Update Submit

May 12, 2023

Conditions

Outcome Measures

Primary Outcomes (7)

  • Proportion of approved patients recruited

    We will deem the study feasible if at least 72% of approached people consent to participate

    Study consent meeting, approx. 1 week after initial meeting

  • Proportion of recruited patients retained

    We will deem the study feasible if least 62% of recruited participants are retained (i.e. receive at least one therapy session and complete the end of therapy measures and interview)

    End of therapy interview

  • Number of participants who receiving the intervention

    We will deem the study feasible if 10 participants receive at least one therapy session

    End of first therapy session, approx. 2 weeks after initial meeting

  • Acceptability (qualitative)

    Qualitative interview with participant at end of therapy analysed using Thematic Analysis

    End of therapy interview

  • Results of Novel Client Measure (descriptive)

    Qualitative self-reported perception of what was helpful about the therapeutic environment

    End of therapy research meeting

  • Results of Outcome Rating Scale (descriptive)

    Qualitative self-report measure assessing areas of life functioning known to change as a result of therapeutic intervention

    End of therapy research meeting

  • Feasibility of adaptions required

    Qualitative record of adaptions required for use of MOL in an acute inpatient setting

    Final follow up meeting with final participant, 3 months after consent

Other Outcomes (5)

  • Psychological Outcomes Profile (descriptive)

    End of therapy research meeting

  • Clinical Outcomes in Routine Evaluation-OM (descriptive)

    End of therapy research meeting

  • Reorganisation of Conflict Scale (descriptive)

    End of therapy research meeting

  • +2 more other outcomes

Study Arms (1)

MOL therapy

EXPERIMENTAL

Participants with Psychosis and/or Suicidality receiving MOL therapy

Other: Method of Levels therapy

Interventions

MOL therapy aims to help people develop awareness of their personal goals so they can identify incompatibilities and find potential solutions. In MOL, the therapist uses a specific style to help people focus attention on the problem at hand, long enough to consider the issues from different perspectives, including reflection on the associated emotions. This process is usually very experiential and requires the client to be actively engaged in controlling the focus of the session and decision making.

MOL therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults over the age of 18 years
  • Current service user in an acute inpatient ward in the Greater Manchester area
  • Capacity to provide informed consent for participating in research
  • Good command of English language
  • WS1: Experiencing psychosis (this will be screened for using a clinical cut-off score on the CAPE (Mossaheb et al., 2012))
  • WS2: Experiencing suicidality (this will be screened for using a cynical cut-off score on the Suicidal Behaviours Questionnaire - revised (SBQ-R) (Osman et al., 2001))

You may not qualify if:

  • Problems of an organic nature or a learning disability that might affect cognitive functioning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

GMMH Park House

Manchester, United Kingdom

Location

GMMH: Laureate House

Manchester, United Kingdom

Location

MeSH Terms

Conditions

Psychotic Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Sara Tai, DClinPsy

    University of Manchester

    PRINCIPAL INVESTIGATOR
  • Yvonne Awenat, PhD

    University of Manchester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ms Lydia Carr, Trainee Clinical Psychologist

Study Record Dates

First Submitted

May 8, 2022

First Posted

May 17, 2022

Study Start

August 10, 2022

Primary Completion

January 30, 2023

Study Completion

February 1, 2023

Last Updated

May 15, 2023

Record last verified: 2023-05

Locations